Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Janssen

Showing results (171-180 of 203) with videos related to

Pageof 21
Sort By:
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|December 13, 2006
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adultsEric E Mast, Cindy M Weinbaum, Anthony E Fiore, et al.
The American Journal of Medicine|July 1, 1988
Human T-cell lymphotropic virus I and adult T-cell leukemia: report of a cluster in North CarolinaJ B Weinberg, R A Spiegel, D L Blazey, et al.
The New England Journal of Medicine|April 16, 1987
An outbreak of thyrotoxicosis caused by the consumption of bovine thyroid gland in ground beefC W Hedberg, D B Fishbein, R S Janssen, et al.
Vaccine|May 18, 2021
An open-label, single-arm study evaluating the immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) in adults receiving hemodialysisAhmed M Awad, Adu Ntoso, Jeffrey J Connaire, et al.
The New England Journal of Medicine|August 13, 1992
HIV infection among patients in U.S. acute care hospitals. Strategies for the counseling and testing of the hospital patients. The Hospital HIV Surveillance GroupR S Janssen, M E St Louis, G A Satten, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 1, 2002
HIV seroincidence among patients at clinics for sexually transmitted diseases in nine cities in the United StatesHillard Weinstock, Monica Dale, Marta Gwinn, et al.
Vaccine|April 21, 2023
Long-term immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B) compared with HepB-Eng (Engerix-B) in adults with chronic kidney diseaseMatthias Girndt, Patricia Houser, Roberto Manllo-Karim, et al.
American Journal of Public Health|June 8, 2001
Two decades after vaccine license: hepatitis B immunization and infection among young men who have sex with menD A MacKellar, L A Valleroy, G M Secura, et al.
Human Vaccines & Immunotherapeutics|October 21, 2022
Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 studyMatthias Girndt, Manfred Plüer, Frank Dellanna, et al.
IJTLD Open|July 14, 2025
Non-tuberculous mycobacterial disease in a high TB/HIV burden settingS Janssen, Z Ismail, T Lovelock, et al.
Pageof 21

Showing results (171-180 of 203) with videos related to

Sort By:
Pageof 21
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|December 13, 2006
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adultsEric E Mast, Cindy M Weinbaum, Anthony E Fiore, et al.
The American Journal of Medicine|July 1, 1988
Human T-cell lymphotropic virus I and adult T-cell leukemia: report of a cluster in North CarolinaJ B Weinberg, R A Spiegel, D L Blazey, et al.
The New England Journal of Medicine|April 16, 1987
An outbreak of thyrotoxicosis caused by the consumption of bovine thyroid gland in ground beefC W Hedberg, D B Fishbein, R S Janssen, et al.
Vaccine|May 18, 2021
An open-label, single-arm study evaluating the immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) in adults receiving hemodialysisAhmed M Awad, Adu Ntoso, Jeffrey J Connaire, et al.
The New England Journal of Medicine|August 13, 1992
HIV infection among patients in U.S. acute care hospitals. Strategies for the counseling and testing of the hospital patients. The Hospital HIV Surveillance GroupR S Janssen, M E St Louis, G A Satten, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 1, 2002
HIV seroincidence among patients at clinics for sexually transmitted diseases in nine cities in the United StatesHillard Weinstock, Monica Dale, Marta Gwinn, et al.
Vaccine|April 21, 2023
Long-term immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B) compared with HepB-Eng (Engerix-B) in adults with chronic kidney diseaseMatthias Girndt, Patricia Houser, Roberto Manllo-Karim, et al.
American Journal of Public Health|June 8, 2001
Two decades after vaccine license: hepatitis B immunization and infection among young men who have sex with menD A MacKellar, L A Valleroy, G M Secura, et al.
Human Vaccines & Immunotherapeutics|October 21, 2022
Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 studyMatthias Girndt, Manfred Plüer, Frank Dellanna, et al.
IJTLD Open|July 14, 2025
Non-tuberculous mycobacterial disease in a high TB/HIV burden settingS Janssen, Z Ismail, T Lovelock, et al.
Pageof 21